Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR8WY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,940
Award facts
- Contract value 100% obligated
- $39,940.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $39,940.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Mounjaro 5 mg/0.5 mL pen injectors (0.5 mL). The order is scheduled for completion by January 7, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. This non-set-aside competitive award was issued as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., which rebranded from AmerisourceBergen Corporation and serves as the primary pharmaceutical distributor for federal military healthcare programs.
The delivery order supports the DLA Medical Supply Chain's ongoing pharmaceutical procurement needs for military treatment facilities and defense health system customers. Mounjaro, a prescription diabetes medication, represents the type of specialty pharmaceutical commodity routinely supplied through the prime vendor contract vehicle. AmerisourceBergen's selection as a prime vendor reflects its demonstrated capability to meet federal procurement standards through open competition and its extensive experience delivering diverse pharmaceutical products—including specialty medications, generic drugs, and medical supplies—across multiple therapeutic domains to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FR8WY?
SPE2DR26FR8WY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FR8WY worth?
The government has obligated $39,940 on SPE2DR26FR8WY.
Is contract SPE2DR26FR8WY an order under another contract?
Yes. SPE2DR26FR8WY is a delivery order under SPE2DR25D3018, an indefinite delivery contract.
Was contract SPE2DR26FR8WY competed?
The extent of competition for SPE2DR26FR8WY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award